Top Factor Driving Genotyping Market Growth in 2025: The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion

How Are the key drivers contributing to the expansion of the genotyping market?
The escalating occurrence of cancer and genetic abnormalities is anticipated to drive the genotyping market's expansion. A myriad of diseases falling under the broad term 'cancer' can originate from virtually any tissue or organ in the body. Genetic disorders, meanwhile, are conditions that are completely or largely caused by deviations in the normal DNA sequence. Genotyping enables researchers to explore genetic variations, including single nucleotide variations, copy number variations, and significant structural alterations in DNA. Genotyping, or genetic testing, searches for unique gene mutations that could heighten a person's likelihood of developing specific cancers. For example, data from the World Health Organization, a Switzerland-based expert agency with an international public health focus, stated that around 20 million fresh cancer cases were recorded in 2022, leading to approximately 9.7 million deaths. At the same time, it was estimated that 53.5 million people survived five years after being diagnosed with cancer. Additionally, Gene People UK, a registered charity based in the UK, reported in February 2023 that 1 in every 25 children suffers from a hereditary condition. This signifies that around 30,000 infants and children are newly diagnosed in the UK each year, and over 2.4 million children and adults have a genetic disorder. As such, the upward trend of cancer and genetic disorders is fueling the expansion of the genotyping market.

Get Your Genotyping Market Report Here:
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

What growth opportunities are expected to drive the genotyping market's CAGR through 2034?
In recent times, there has been a significant surge in the size of the genotyping market. The market, which was valued at $23.04 billion in 2024, is predicted to increase to $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The previous growth can be credited to numerous factors such as government schemes and funding, a quick reduction in genotyping costs, the growth of biobanks and genetic databases, rising incidences of genetic disorders, and progress in pharmacogenomics and drug development.

The genotyping market is projected to undergo swift expansion in the upcoming years. Its predicted growth will peak at $51.43 billion in 2029, showing a compound annual growth rate (CAGR) of 17.9%. Factors contributing to this predicted surge within the forecast period include a greater incorporation in clinical diagnostics, a rise in demand for tailored medicine, increased R&D activities, and their growing utilisation within agriculture and livestock fields. The forecast period is also expected to see trends such as an increasing demand for pharmacogenomics, breakthroughs in next-generation sequencing (ngs), growth in precision medicine initiatives, the rise in direct-to-consumer (dtc) genetic testing, alongside a dedicated emphasis on cancer genomics and personalized therapies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

What are the emerging trends shaping the future of the genotyping market?
Innovations in product development are becoming a significant trend in the genotyping market. To maintain their market position, companies in the genotyping sector are turning to groundbreaking solutions. Illustratively, Neogen, a food safety enterprise based in the U.S., partnered with Gencove Inc., a stateside sequencing platform provider for genome discovery, to launch InfiniSEEK in May 2022. This inventive solution, cost-efficient for whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis, is a first-of-its-kind for cattle breeders. Thanks to InfiniSEEK, the sector now possesses a reliable platform to manage over 400 bovine genetic features and conditions, discover fresh variables influencing desirable phenotypes, and reduce selection bias by providing sequencing for more or the entire population. With this service's launch, customers can now take advantage of a cost-effective, data-rich method for profiling cattle globally by merging genome-wide sequencing data with specific genetic traits and parentage indicators.

Which growth-oriented segments of the genotyping market are leading the industry's development?
The genotyping market covered in this report is segmented -

1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service
2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies
3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users

Subsegments:
1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms
2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits
3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions
4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12059

What regions are leading the charge in the genotyping market?
North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the genotyping market?
Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

What Is Covered In The Genotyping Global Market Report?

• Market Size Forecast: Examine the genotyping market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the genotyping market for a structured understanding.
• Key Players Overview: Analyze major players in the genotyping market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the genotyping market.
• Segment Contributions: Evaluate how different segments drive overall growth in the genotyping market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the genotyping market.
• Industry Challenges: Identify potential risks and obstacles affecting the genotyping market.
• Competitive Landscape: Review strategic developments in the genotyping market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.